Imaging findings of recurrent pancreatic cancer following resection.
Sanaz JavadiN KarbasianP BhosaleS de Castro FariaO LeM H KatzE J KoayE P TammPublished in: Abdominal radiology (New York) (2019)
Pancreatic cancer is a challenging malignancy to treat, largely due to aggressive regional involvement, early systemic dissemination, high recurrence rate, and subsequent low patient survival. Generally, 15-20% of newly diagnosed pancreatic cancers are candidates for possible curative resection. Eighty percent of these patients, however, will experience locoregional or distant recurrence in first 2 years. Although there is no strong evidence-based guideline for optimal surveillance after pancreatic cancer resection, careful comparison of surveillance follow-up multi-detector CT (MDCT) studies with a postoperative baseline MDCT examination aids detection of early recurrent pancreatic cancer. In this review article, we describe imaging findings suggestive of recurrent pancreatic cancer and review routine and alternative imaging options.
Keyphrases
- newly diagnosed
- high resolution
- public health
- end stage renal disease
- prognostic factors
- free survival
- ejection fraction
- patients undergoing
- computed tomography
- chronic kidney disease
- lymph node
- clinical practice
- peritoneal dialysis
- fluorescence imaging
- rectal cancer
- young adults
- loop mediated isothermal amplification
- drug induced